Tag
MAGIC is a research paper exploring malicious aging attacks in circuits and cores, focusing on hardware security implications.
Researchers quantitatively assessed for the first time that somatic mutations alone cap human lifespan at 146–194 years, with brain and heart cells as the main bottleneck, while the liver could last millennia.
A new study suggests that multilingual experience is linked to delayed aging, offering potential cognitive benefits.
A subscriber-only roundtable discussion hosted by MIT Technology Review explores the frontier of longevity research, focusing on cellular reprogramming as a potential treatment to reverse aging.
WIRED profiles Stewart Brand, the 87-year-old tech visionary behind the Whole Earth Catalog, and the specially designed house he and his wife built to accommodate his aging and illness, embodying his ethos of self-sufficiency and maintenance.
This newsletter covers two major tech stories: a biotech company's first human trial of 'reprogramming' cells to reverse aging, and the growing field of interoception research. It also notes SpaceX's record-breaking IPO.
A biotech company has dosed its first volunteer in a clinical trial for an experimental glaucoma treatment that uses cellular reprogramming to reverse age-related damage, part of a broader trend toward rejuvenation therapies.
A 2025 research article explores how a single molecule can maintain plants in a youthful state, potentially impacting agricultural longevity.
Brian Armstrong announces that NewLimit has developed a prototype drug that reverses cellular aging in human cells, with a clinical trial scheduled for next year, and has raised $435M in Series C funding led by Founders Fund.
Dr. Derya Unutmaz suggests humanity may be approaching longevity escape velocity, where each year lived could grant over one extra year of life, potentially saving millions if achieved sooner.
Calico Life Sciences uses Google DeepMind's Co‑Scientist to connect scattered findings in aging biology and generate testable hypotheses, such as a novel hypothesis about ISR regulation by metabolism.